BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16546858)

  • 1. Efficacy of systemic therapy in advanced pancreatic carcinoma.
    Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
    Acta Oncol; 2006; 45(2):136-43. PubMed ID: 16546858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced pancreatic cancer: current therapeutic approach.
    Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
    Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer: from molecular signature to target therapy.
    Longo R; Cacciamani F; Naso G; Gasparini G
    Crit Rev Oncol Hematol; 2008 Dec; 68(3):197-211. PubMed ID: 18436450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern systemic therapy of advanced pancreatic cancer: impact on overall survival and medico economical aspects].
    Mazzuri S; Roth A
    Rev Med Suisse; 2005 Jun; 1(24):1616-20. PubMed ID: 16028707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature.
    Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O
    Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of patients with gastric adenocarcinoma.
    Foukakis T; Lundell L; Gubanski M; Lind PA
    Acta Oncol; 2007; 46(3):277-85. PubMed ID: 17450463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems of antineoplastic chemotherapy of pancreatic cancer].
    Matthias M; Wolff H
    Zentralbl Chir; 1987; 112(21):1322-36. PubMed ID: 3324556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in preclinical and early-stage clinical development for pancreatic cancer.
    Asuthkar S; Rao JS; Gondi CS
    Expert Opin Investig Drugs; 2012 Feb; 21(2):143-52. PubMed ID: 22217246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer: standards for the 21st century.
    Archie V; Kauh J; Jones DV; Cruz V; Karpeh MS; Thomas CR
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):123-31. PubMed ID: 16412659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials referral resource. Current phase II and phase III clinical trials for pancreatic cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Jul; 18(8):1008, 1013-4, 1016. PubMed ID: 15328895
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment for pancreatic cancer: current therapy and continued progress.
    Lockhart AC; Rothenberg ML; Berlin JD
    Gastroenterology; 2005 May; 128(6):1642-54. PubMed ID: 15887156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The medical management of pancreatic cancer: a review.
    McKenna S; Eatock M
    Oncologist; 2003; 8(2):149-60. PubMed ID: 12697940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in Systemic Therapy for Pancreatic Cancer.
    Brown TJ; Reiss KA; O'Hara MH
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e397082. PubMed ID: 37192430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer in young adults: changes, challenges, and solutions.
    Primavesi F; Stättner S; Schlick K; Kiesslich T; Mayr C; Klieser E; Urbas R; Neureiter D
    Onco Targets Ther; 2019; 12():3387-3400. PubMed ID: 31118690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Therapy of Pancreatic Cancer: Better Science, Faster Progress.
    Philip PA
    Oncology (Williston Park); 2015 Nov; 29(11):821, 826. PubMed ID: 26573061
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
    Yu WD; Ma Y; Flynn G; Muindi JR; Kong RX; Trump DL; Johnson CS
    Cell Cycle; 2010 Aug; 9(15):3022-9. PubMed ID: 20699664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.